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Abstract 
Molecular imaging is a newly emerged multiple disciplinary field that aims to visualize, char-
acterize and quantitatively measure biological processes at cellular and molecular levels in 
humans and other living systems. A reporter gene is a piece of DNA encoding reporter 
protein, which presents as a readily measurable phenotype that can be distinguished easily 
from the background of endogenous protein. After being transferred into cells of organ 
systems  (transgenes),  the  reporter  gene  can  be  utilized  to  visualize  transcriptional  and 
posttranscriptional regulation of gene expression, protein-protein interactions, or trafficking 
of proteins or cells in living subjects. Herein, we review previous classification of reporter 
genes and regroup the reporter gene based imaging as basic, inducible and activatable, based 
on the regulation of reporter gene transcription and post-translational modification of re-
porter proteins. We then focus on activatable reporters, in which the signal can be activated 
at the posttranslational level for visualizing protein-protein interactions, protein phosphor-
ylation or tertiary structure changes. The applications of several types of activatable reporters 
will also be summarized. We conclude that activatable reporter imaging can benefit both basic 
biomedical research and drug development. 
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Introduction 
Recently, molecular imaging has been evolved to 
be an important tool for both preclinical research and 
clinical  applications.  By  converging  multiple  disci-
plinary subjects, the new imaging paradigm aims to 
visualize,  characterize  and  measure  quantitatively 
biological processes at the cellular and molecular lev-
els in humans and other living systems [1]. Advanced 
multiple  molecular  imaging  modalities  are  of  great 
value  in  a  wide  array  of  biomedical  applications 
ranging from reflecting specific cellular and molecular 
processes  including  gene  expression  or  pro-
tein–protein interactions to optimizing drug and gene 
therapy [2].  
The  reporter  genes  form  the  basis  of  reporter 
gene expression imaging in living subjects, a subfield 
of molecular imaging [3]. A reporter gene is a piece of 
DNA  encoding  reporter  protein  molecules,  which 
represents a readily measurable phenotype that can 
be distinguished easily from the background of en-
dogenous proteins [3, 4]. Different from the methods 
including tissue biopsy, sampling and in situ hybrid-
ization, reporter gene imaging provides a noninvasive 
way to evaluate the location, magnitude, and extent of 
gene  expression  in  a  living  subject  [5].  After  being 
externally  transferred  into  cells  of  organ  systems 
(transgenes) or endogenous genes, molecular imaging 
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with  reporter  genes  have  been  utilized  to  visualize 
transcriptional  and  posttranscriptional  regulation  of 
gene expression, protein-protein interactions, or traf-
ficking of proteins or cells in living subjects [3].  
Classification of reporter genes 
Intracellular vs. cell membrane reporter genes 
In  fact,  long  before  the  concept  of  molecular 
imaging  was  coined,  reporter  genes  have  been  in-
vented and adopted by scientists to follow transgenic 
expression either macroscopically or microscopically 
[6, 7]. As part of the evolving concept of molecular 
medicine, molecular imaging technologies have been 
developed  to  examine  the  integrative  functions  of 
molecules, cells, organ systems, and whole organisms 
[8]. Consequently, reporter genes have been involved 
with many different imaging technologies as an im-
portant subfield of molecular imaging. There are sev-
eral ways to categorize reporter genes. A broad clas-
sification of the reporter genes could be made based 
on the cellular localization of the gene products, either 
being intracellular or associated with the cell mem-
brane [9]. Examples of the former include green fluo-
rescent protein (GFP), luciferases, cytosine deaminase, 
and thymidine kinase. Examples of reporter proteins 
on or in the cell surface include the receptors for so-
matostatin  or  transferrin  and  the  sodium  iodide 
symporter [9, 10].  
Imaging modality specific reporter genes 
An application-oriented classification strategy is 
based  on  the  different  imaging  modalities  used  for 
visualization  of  a  particular  reporter  gene.  Almost 
every imaging modality used for molecular imaging 
has the corresponding reporter genes available. Posi-
tron emission tomography (PET) is the most sensitive 
and  specific  technique  for  imaging  molecular  path-
ways in vivo in humans [11]. So far, the most popular 
PET reporter genes are herpes simplex virus type 1 
thymidine kinase (HSV-tk) [12, 13] and human or rat 
sodium iodide symporter (hNIS or rNIS) [14, 15]. 
Non-radionuclide-based imaging techniques in-
clude magnetic resonance imaging (MRI), ultrasound 
and optical imaging. MRI is a noninvasive diagnostic 
technique based on the interaction of protons (or other 
nuclei) with each other and with surrounding mole-
cules in a tissue of interest [16]. Different tissues have 
different relaxation times which can result in endog-
enous contrast. The major advantage of MRI over ra-
dionuclide-based imaging is the absence of radiation 
and higher spatial resolution (usually sub-millimeter 
level). The major disadvantage of MRI is its inherent 
low sensitivity, which makes it very difficult for re-
porter  gene  MRI  to  get  decent  target/background 
signal ratio in vivo [17]. Native ferritin has been used 
as  MRI  reporter  gene  since  it  can  concentrate  the 
body’s natural iron to the amount detectable by MRI 
[18, 19]. There is no reporter gene suitable for ultra-
sound imaging so far.  
Two main branches of optical imaging are fluo-
rescence  imaging  and  bioluminescence  imaging.  In 
fluorescence imaging, excitation light illuminates the 
subject, and a charge-coupled device (CCD) camera 
collects the emission light at a shifted wavelength [2]. 
A  series  of  fluorescent  proteins,  such  as  the  green 
fluorescent  protein,  have  also  enabled  sophisticated 
studies  of  protein  function  and  wide-ranging  pro-
cesses  from  gene  expression  to  second-messenger 
cascades and intercellular signaling, typically through 
fusion  protein  approach  rather  than  through  direct 
labeling [20]. The major limitation of optical imaging 
is  tissue  light  scattering  and  absorption  that  affect 
both image resolution and depth of light penetration 
of  tissues  [21].  Bioluminescence  imaging  (BLI)  is 
based on the expression of luciferases in target cells 
and tissues [22]. In the presence of its substrate (such 
as D-luciferin), an energy-dependent reaction releases 
photons that can be detected using sensitive detection 
systems. BLI has been used to study gene-expression 
patterns [22], to measure gene transfer efficiency [23], 
to  monitor  tumor  growth  and  response  to  therapy 
[24], to investigate protein–protein interactions in vivo 
[25, 26], and to determine the location and prolifera-
tion of stem cells [27]. The most commonly used biolu-
minescence reporter gene for research purposes has been the 
luciferase from the North American firefly (Photinus Pyra-
lis, Fluc) [28].  
Basic, inducible and activatable reporter imaging  
Based  on  the  regulation  of  reporter  gene  tran-
scription  and  post-translational  modification  of  the 
proteins encoded by the different reporter genes, we 
categorized  the  reporter  systems  into  three  sub-
groups:  basic,  inducible  and  activatable.  Most  com-
monly used reporter gene system consists of a con-
stitutive  promoter  and  a  coding  sequence  for  a  re-
porter  protein.  For  example,  Fluc  expressing  vector 
driven by CMV promoter has been intensively used as 
a reporter system for tumor growth monitoring, es-
pecially  for  orthotropic  tumor  models  [29].  Vectors 
encoding HSV-tk has been used to transduce T cells 
for in vivo cell trafficking study by SPECT and PET 
[30]. The proportional correlation between the imag-
ing signal and the constant expression of the reporter 
proteins  guarantees  accurate  quantification  of  the 
images. 
With an inducible reporter gene system, the ex-
pression of the reporter genes is regulated or manip-Theranostics 2012, 2(4) 
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ulated  at  the  transcriptional  or  post-transcriptional 
level. The most common strategy is to introduce spe-
cific promoter/enhancer elements before the reporter 
gene.  Thus  the  transcription  and  expression  of  the 
reporter  gene  is  regulated  by  corresponding  tran-
scription  factors.  One  example  is  HIF-1,  which  in-
volves  one  of  the  most  intensively  studied  oxygen 
response pathways in molecular biology. Under hy-
poxic  conditions,  accumulated  HIF-1  binds  to  the 
hypoxia  responsive  element  (HRE)  and  triggers  the 
recruitment  of  co-activators  essential  for  transcrip-
tional activation  [31]. Several elegant methods have 
been developed to directly measure HIF-1 activity by 
the introduction of transgenes with HREs as promoter 
sequences coupled to reporter genes such as luciferase 
[32,  33]  or  GFP  [34].  Another  example  is  that 
heat-shock  protein  promoters,  particularly  HSP70 
promoters, have been commonly used for gene ther-
apy  strategies  because  they  are  both  heat-inducible 
and efficient [35]. GFP has been utilized extensively as 
the reporter gene to evaluate the spatial and temporal 
control of gene expression driven by HSP70 promot-
ers  [36-39].  With  PET  imaging,  spontaneous  in vivo 
activation of the HSV1-tk suicide gene driven by the 
Grp78  promoter,  a  member  of  HSP70  family,  in 
growing tumors and its activation by photodynamic 
therapy (PDT) in a controlled manner has been ob-
served [40]. Noguchi et al. [41] have established a du-
al-color transgenic mouse that carries transgenes en-
coding green-emitting luciferase (ELuc, λmax = 538 
nm)  expressed  under  the  control  of  the  Bmal1  pro-
moter  and  red-emitting  luciferase  (SLR2,  λmax=630 
nm) expressed under the control of the Per2 promoter. 
Consequently, the antiphasic oscillations of Bmal1 and 
Per2 expression were able to be monitored simulta-
neously in a single tissue of the dual-color luciferase 
mouse by splitting their emissions. 
MicroRNAs  (miRNAs)  are  approximately 
21-nucleotide  (nt)  single-stranded,  small  noncoding 
RNAs acting as post-transcriptional regulators of gene 
expression  in  animals  and  plants  [42].  To 
non-invasively  image  and  quantify  endogenous 
miRNAs in vivo, Kim et al. [43] developed a Gaussia 
princeps  luciferase  (Gluc)  imaging  system  in  which 
three perfectly matched complementary sequences of 
miR-221 was fused immediately after the stop codon 
of  Gluc  reporter  vector.  Then  the  transcript  of  this 
vector  was  expected  to  be  bound  by  endogenous 
miR-221,  thus  the  transcript  of  Gluc  would  be  de-
graded. Consequently, the translation of Gluc would 
be suppressed, resulting in a decrease of biolumines-
cent  signal.  This  study  provides  an  example  of  re-
porter  genes  which  can  be  induced  at  the 
post-transcriptional level. 
The  ability  to  noninvasively  image  pro-
tein–protein  interactions  has  important  implications 
for a wide variety of biological research endeavors, 
including  drug  discovery  and  molecular  medicine 
[44].  There  are  three  popular  strategies  to  visualize 
protein-protein interaction by molecular imaging in-
cluding  modified  mammalian  two-hybrid  system, 
bioluminescence  resonance  energy  transfer  (BRET) 
technology and split reporter genes. The two-hybrid 
system is fairly simple, rapid and the strategies de-
veloped  should  be  generally  applicable  for  many 
protein partners, as long as the interaction complex 
can lead to transactivation of the reporters of choice. 
The main limitation is that it can only be used to de-
tect interacting proteins in the nucleus [44]. Through 
non-radioactive transfer of energy between donor and 
acceptor  molecules  by  the  Förster  mechanism,  both 
FRET  and  BRET  are  capable  of  studying  pro-
tein-protein interactions. However, in vivo application 
is limited because of the high requirement for sepa-
rating emissions between the donor and the acceptor 
[26].  
Activatable reporter gene imaging 
With  the  advance  of  molecular  imaging  tech-
niques,  more  sophisticated  strategies  have  been 
adapted  for  the  design  of  reporter  gene  system  to 
broaden their biomedical applications. One category 
of  reporter  genes  can  be  activated  at  the 
post-translational  level  with  protein-protein  interac-
tion, enzymatic reaction, phosphorylation or tertiary 
structure changes [45]. In order to distinguish these 
reporter systems from those inducible reporter gene 
imaging, we named them here as “activatable reporter 
gene imaging”. Most of split reporter genes designed 
to  image  protein-protein  interactions  fall  into  this 
category. 
Imaging protein-protein interaction 
The principle mechanism of split reporter gene 
lies in that splitting a specific reporter protein into two 
distinct fragments abolishes its function and bringing 
the  two  fragments  back  together  in  a  controlled 
manner restores the functional activity [46]. To date, 
several  reporter  proteins  (e.g.  β-lactamase, 
β-galactosidase,  ubiquitin,  dihydrofolate  reductase, 
luciferases and GFP) have been adapted for split pro-
tein strategies by finding various split sites for each 
reporter protein [47-50]. For in vivo imaging, luciferase 
is the most popular reporter protein to be split apart. 
Firefly luciferase has been cleaved into two fragments 
as Nfluc (residues 1–437) and Cfluc (residues 438–550) 
and fused to Id and MyoD respectively as test pro-
teins [48].  Theranostics 2012, 2(4) 
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The  rapamycin-induced  interaction  between 
FKBP12  (FK506  binding  protein)  and  FRB 
(FKBP–Rapamycin  binding  domain)  can  be  consid-
ered a textbook example of a re-usable protein inter-
action device [51]. The crystal structure of the ternary 
complex of FKBP12 and FRB revealed extensive in-
teractions between rapamycin and both proteins, but 
fewer  interactions  between  the  proteins  [52].  With 
alternative  complementary  N-  and  C-terminal  frag-
ments  of  Fluc,  Luker  et al.  [53]  monitored  rapamy-
cin-mediated  interaction  of  rapamycin  binding  pro-
teins FRB and FKBP12 using two fragments of Fluc 
(residues 2–416 and 398–550).  
Hida et al. [54] fused fragments from firefly lu-
ciferase, click beetle luciferase in green and click bee-
tle luciferase in red with FRB and FKBP12. By muta-
tion of the C-terminal fragment from the click beetle 
luciferase,  they  developed  an  imaging  method  for 
real-time analysis of protein-protein interactions us-
ing  multicolor  luciferases  with  different  spectral 
characteristics. They applied this method to visualize 
protein-protein  interactions  of  Smad  proteins  and 
demonstrated Smad1–Smad4 and Smad2–Smad4 in-
teractions in early developing stages of a single living 
Xenopus  laevis  embryo.  This  technique  supports 
quantitative  analysis  and  imaging  of  versatile  pro-
tein-protein interactions with a selective luminescence 
wavelength  in  opaque  or  strongly  autofluorescent 
living subjects. 
Mammalian target of rapamycin (mTOR) plays 
critical  roles  in  regulating  protein  synthesis  and 
growth,  ribosomal  protein  synthesis,  cell  cycle,  au-
tophagy and apoptosis of eukaryotic cells [55]. As a 
potent  immunosuppressant,  Rapamycin  was  ap-
proved by the Food and Drug Administration (FDA) 
in 1999 for use in kidney  transplant recipients  [56]. 
Later on, rapamycin has been found to be a potential 
anticancer  drug,  since  it  can  act  as  a  cytostatic,  ar-
resting  cells  in  G1  phase  or  potentially  inducing 
apoptosis,  in  many  malignant  cells  in  culture  [57]. 
Rluc  fragmentation  generated  by  splitting  between 
residues 229 and 230 has been used to study rapamy-
cin-induced  interaction  of  the  human  proteins  FRB 
and FKBP12 [58]. In the range from 0.2 nM to 10 nM, 
bioluminescence signal intensity increased along with 
the  rapamycin  concentration,  implying  that  the  re-
porter gene system could be applied to monitor drug 
delivery. 
Imaging protein trafficking 
Nucleocytoplasmic  trafficking  of  functional 
proteins plays a key role in regulating gene expres-
sions in response to extracellular signals [59]. Kim et 
al. [60] developed an activatable BLI reporter system 
for monitoring and imaging the nuclear trafficking of 
target proteins in vitro and in vivo. The assay is based 
on the reconstitution of split fragments of Renilla ren-
iformis  luciferase  (Rluc)  by  protein  splicing  with  a 
DnaE intein. A target cytosolic protein fused to the 
N-terminal half of Rluc is expressed in mammalian 
cells. If the protein translocates into the nucleus, the 
Rluc moiety meets the C-terminal half of Rluc and the 
full-length  Rluc  is  reconstituted  by  protein  splicing 
(Figure  1).  The  authors  demonstrated  quantitative 
cell-based in vitro sensing and in vivo imaging of lig-
and induced translocation of the androgen receptor, 
which allowed high-throughput screening of exoge-
nous and endogenous agonists and antagonists. Fur-
thermore,  the  reporter  gene  enabled  noninvasive  in 
vivo imaging of the androgen receptor translocation in 
the brains  of living  mice,  justifying the potential of 
this strategy for drug screening. 
Imaging physiopathological pathways 
One advantage of activatable reporter genes lies 
in that the design is complicated enough to be used 
for  visualization  and  quantification  of  particular 
physiological or pathological pathways directly. One 
example is the bioluminescent Akt reporter for Akt 
activity  imaging  [61].  The  serine/threonine  kinase 
Akt  functions  as  a  signaling  hub  where  many  up-
stream  signaling  pathways  converge  [62].  Because 
Akt and its upstream regulators are dysregulated in 
some forms of cancer, they are promising targets for 
pharmaceutical intervention [63, 64]. Zhang et al. [61] 
have constructed a bioluminescent Akt reporter that 
contains  an  Akt  consensus  substrate  peptide 
(Akt-pep)  and  a  domain  that  binds  phosphorylated 
amino  acid  residues  (FHA2)  flanked  by  the 
N-terminal (N-Luc) and C-terminal (C-Luc) domains 
of  the  firefly  luciferase  reporter  molecule.  The 
reporter has minimal bioluminescence activity when 
Akt-dependent  phosphorylation  of  the  Akt-pep 
domain  results  in  its  interaction  with  the  FHA2 
domain. In the absence of Akt activity, the N-Luc and 
C-Luc domains reassociate, restoring bioluminescence 
activity  (Figure  2).  With  this  reporter  construction, 
Akt  activity  in  cultured  cells  and  tumor  xenografts 
can be monitored quantitatively and dynamically in 
response to activation or inhibition of receptor tyro-
sine kinase, inhibition of phosphoinositide 3-kinase, 
or direct inhibition of Akt.  
Cyclic  adenosine  monophosphate  (cAMP)  is  a 
key  second  messenger  of  signal  transduction  in 
mammalian cells and cAMP levels have been shown 
to rise and fall rapdily within the cell following re-
ceptor activation and response desensitization [65]. A 
cAMP biosensor has been developed by introducing a Theranostics 2012, 2(4) 
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cAMP-binding domain B from protein kinase A reg-
ulatory  subunit  type  IIβ  (RIIβB)  into  a  circularly 
permuted  a  circularly  permuted  form  of  Photinus 
pyralis luciferase [66]. An evolved version of this bio-
sensor construct was able to accurately track both the 
magnitude and kinetics of cAMP change in living cell 
environment [67]. 
 
 
 
 
Figure 1. Basic strategy for the detection of AR translocation. A. Principle for monitoring translocation of a particular protein (X) into 
the nucleus using protein splicing of split-Rluc. RLuc-N (1-229 aa) is connected with DnaE-N (1-123 aa) and NLS [(DPKKKRKV)3], which 
is predominantly localized in the nucleus. DnaE-C (1-36 aa) is connected with RLuc-C (230-311 aa) and a protein X, which is localized in 
the cytosol. When the tandem fusion protein consisting of DnaE-C, Rluc-C, and protein X translocates into the nucleus, the DnaE-C 
interacts with DnaE-N, and protein splicing results. Rluc-N and -C are linked by a peptide bond, and the reconstituted Rluc recovers its 
bioluminescence activity. FLAG means epitope (DYKDDDDK). B. The inhibitory effect of chemicals on AR translocation into the nucleus 
in the mouse brain. The COS-7 cells transiently cotransfected with pcRDn-NLS and pcDRc-AR were implanted in the forebrain of the 
nude mice at a depth of 3 mm through a 1-mm burrhole. Of mouse groups 1–4, groups 1 and 2 were stimulated with1%DMSO, whereas 
groups 3 and 4 were stimulated with procymidone (10 mg/kg body weight) and PCB (10 mg/kg of body weight), respectively. Two hours 
after the stimulation, mouse groups 2–4 were then stimulated with DHT (10µg/kg of body weight). Two hours after DHT stimulation, the 
mice were imaged in 2-min intervals until reaching the maximum photon counts after intercerebral injection of coelenterazine (1.4 mg/kg 
of body weight). Reproduced with permission from ref. 60. Theranostics 2012, 2(4) 
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Figure 2. Biolumienscent Akt reporter (BAR). A. The domain structure (upper) and the proposed mechanism of action (lower) of the 
BAR reporter. It involves Akt-dependent phosphorylation of the Akt-pep domain (thick line), which results in its interaction with the 
FHA2 domain (right). In this form, the reporter has minimal bioluminescence activity. In the absence of Akt activity, the N-Luc and C-Luc 
domains reassociate, restoring bioluminescence activity (left). B. Bioluminescence imaging of Akt kinase activity. Bioluminescence activity 
before treatment (time 0) and in response to treatment with API-2 (20 mg/kg or 40 mg/kg) was monitored at various times. Reproduced 
with permission from ref. 61. 
 
 
Apoptosis, or programmed cell death, is an ac-
tive regulatory mechanism functionally opposite but 
complementary to proliferation. As a tightly regulated 
multi-step pathway, apoptosis plays a crucial role in 
many  biological  processes  and  various  diseases, 
which  are  characterized  by  relative  excess  of  cell 
death [68]. As the cell undergoes apoptosis, there are a 
number of potential steps in the process that could be 
imaged  using  very  different  imaging  modalities. 
Caspases play a central role in the execution of cell 
death. Both the intrinsic (mitochondrial) and extrinsic 
(death  receptor)  pathways  of  apoptosis  eventually 
activate several effector caspases [69]. Among them, 
Caspase-3 is one of the key effector caspases which 
recognizes and cleaves DEVD (aspartic acid-glutamic 
acid-valine-aspartic acid) peptide sequence that exists 
in  many  cellular  proteins  such  as  poly(ADPribose) 
polymerase  and  lamins  [70].  Several  activatable  re-
porter genes have been reported to image caspase-3 
activity  in  vivo  (Figure  3).  Laxman  et  al.  [71]  con-
structed a reporter gene vector containing firefly lu-
ciferase gene flanked by the ER (residues 281–599 of 
the modified mouse estrogen receptor sequence) with 
the  DEVD  linker.  In  cells  undergoing  apoptosis,  a 
caspase-3-specific cleavage of the recombinant prod-
uct  resulted  in  the  restoration  of  luciferase  activity 
that can be detected in living animals with BLI.  
Another reporter, ANLucBCLuc , has been de-
signed to image caspase-3 activity in living cells and 
animals  [72].  The  reporter  constituted  a  fusion  of 
small interacting peptides, peptide A and peptide B, 
with the NLuc and CLuc fragments of luciferase with 
a caspase-3 cleavage site (DEVD) between pepANLuc 
(ANLuc) and pepBCLuc (BCLuc). During apoptosis, 
caspase-3 cleaves the reporter, enabling the separation 
of  ANLuc  from  BCLuc.  A  high-affinity  interaction 
between peptide A and peptide B restores luciferase 
activity by NLuc and CLuc complementation. Treat-
ment of live cells and mice carrying D54 tumor xeno-
grafts  with  chemotherapeutic  agents  and  radiation 
resulted in increased bioluminescence activity due to 
enhanced apoptosis [72]. Ray et al. applied a multi-
modality reporter vector to monitor caspase-3 activa-
tion indirectly in live cells and tumors of living ani-
mals undergoing apoptosis. In their study, a fusion 
protein  (MTF)  was  constructed  by  combining  three 
different  reporter  proteins--  red  fluorescent  protein 
(mRFP1), firefly luciferase (FL), and HSV1-sr39 trun-
cated  thymidine  kinase  (TK)--linked  through  a 
caspase-3  recognizable  polypeptide  linker.  Upon 
apoptosis induction with 8 µM staurosporine, the fu-
sion protein showed significant increases in FL and 
mRFP1 activity in 293T cells [73]. A DEVD containing 
cyclic luciferase to detect caspases activation has also 
been reported [74, 75]. In these studies, two fragments 
of  DnaE  intein  were  fused  to  neighboring  ends  of 
firefly  luciferase  connected  with  a  DEVD  sequence. 
After translation into a single polypeptide in  living Theranostics 2012, 2(4) 
 
http://www.thno.org 
419 
cells, the amino (N) and carboxy (C) terminals of the 
luciferase  are  ligated  by  protein  splicing,  which  re-
sulted in a closed circular polypeptide chain. When 
the substrate sequence was digested by caspases, the 
luciferase changed into an active form and restored its 
activity.  Doxil  induced  apoptosis  has  been  success-
fully visualized by BLI non-invasively [76]. 
 
 
 
 
 
 
Figure 3. Activatable reporter gene systems for imaging of caspase 3 activities. A. Activation of caspase-3 cleaves the MTF fusion protein 
into the three reporter protein components. Upon cleavage, the reporter proteins (mRFP1, FL, andTK) with attenuated activity in fused 
form (MTF) gain significantly higher activity and can be used for noninvasive imaging of apoptosis. Reproduced with permission from ref. 
73. B. Chimeric polypeptides consisting of a reporter molecule fused to the ER resulted in silencing of the reporter activity. Inclusion of 
a protease cleavage site between these domains provided for protease-mediated activation of the reporter molecule after separation of 
the silencing domains (i.e., ER). Reproduced with permission from ref. 71. C. The ANLucBCLuc apoptosis imaging reporter constitutes 
the split luciferase (NLuc and CLuc) domains fused to interacting peptides, peptide A and peptide B, with an intervening caspase-3 cleavage 
motif. Upon induction of apoptosis, the reporter molecule is proteolytically cleaved by caspase-3 at the DEVD motif. This cleavage enables 
interaction between pepANLuc and pepBCLuc, thus reconstituting luciferase activity. Reproduced with permission from ref. 61 72. D. For 
an efficient protein splicing reaction, the C- and N-terminal fragments of DnaE (DnaEc and DnaEn, respectively) are connected with the 
N- and C-terminal ends of the circularly permuted luciferase. In addition, a PEST sequence was attached to the C-terminal end of the 
fusion construct to accelerate degradation of a protein. The PEST sequence results in the degradation of only unspliced products because 
cyclic Fluc does not possess the PEST sequence. Consequently, only cyclic Fluc accumulates inside the cells. If caspase-3 is activated in cells 
expressing the cyclic Fluc, the Fluc changes into an active form and its luminescence activity is restored. Thus, cells expressing the cyclic 
Fluc allow monitoring of caspase-3 activity with luminescence signals. Reproduced with permission from ref. 74 
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PET split reporter genes 
A major disadvantage of optical imaging is the 
low tissue penetration of light. Owing to absorption 
and scattering, light in the visible spectrum emitted 
by fluorescence has only a limited tissue penetration 
of  several  hundred  micrometers.  This  problem  re-
stricts  the  application  of  most  optical  methods  to 
small animals or to the study of surface structures in 
humans [77]. PET reporter genes have the potential to 
provide a sensitive and more accurate means of fully 
quantitative in vivo imaging and precise tomographic 
localization  of  protein-protein  interactions  (PPIs) 
deeper in the body than optical bioluminescence im-
aging  using  split  luciferase,  since  BLI  is  relatively 
surface weighted and semiquantitative in nature [78]. 
The HSV-tk enzyme phosphorylates a wide range of 
nucleoside  analogs.  Consequently,  radiolabeled  re-
porter  probes  such  as  123I-FIAU  and  18F-FHBG  are 
transported into cells and are trapped as a result of 
phosphorylation by HSV-tk to facilitate PET or SPECT 
imaging [79]. Recently, Massoud et al. [78] indentified 
a split  point  of the TK enzyme between Thr265 and 
Ala266 after a partial circular permutation screen. They 
successfully engineered the first PET based split re-
porter system to be used for protein fragment com-
plementation assay (PCA) (Figure 4).  
 
 
 
Figure 4. Split thymidine kinase reporter gene for imaging of protein-protein interaction. A. Simplified schematic diagram representing 
the forward or ‘folding’ mechanism underlying a proteinfragment complementation assay (PCA). B. Transaxial tomographic microPET 
images through a representative prone-positioned mouse implanted subcutaneously over the left shoulder with mock-transfected 293T 
cells, and over the right shoulder with 293T cells stably expressing both nTK(V119C)-FRB and FKBP12-cTK. The mouse was injected with 
200 μCi of [18F]-FHBG before imaging on days 1, 2 and 5 into the imaging protocol (that is, after 7 d of initial xenograft growth). Elliptical 
dotted white line outlines the surface of the mouse’s upper thorax. Color intensity is a reflection on probe accumulation after its 
phosphorylation by the complemented thymidine kinase enzyme. Reproduced with permission from ref. 78. 
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Design of activatable reporter gene imaging 
With regard to protein engineering to design an 
activatable reporter gene, two main issues need to be 
considered. One is how to decide the cleave site to 
make both fragments have no residual activity. An-
other is how to fully restore the enzyme function after 
fragment complementation. A detailed knowledge of 
protein structure, function and mechanism would be 
of great help in reporter  gene engineering  [80]. For 
example, the crystal structure of luciferase shows two 
essentially  independent  folding  domains,  the 
N-terminal domain consisting of residues 1–436 and a 
C-terminal  domain  consisting  of  residues  440–550, 
connected by a disordered flexible region [81]. Con-
stitutive activity of the N terminus fragment has been 
observed  when  firefly  luciferase  was  split  between 
amino acid positions 437 and 438 [48]. Further study 
revealed that fragmentation of NLuc (2-416) and CLuc 
(398-550) deleted key structural and active site regions 
from  the  N-terminal  fragment  and,  in  effect,  trans-
ferred these regions to the C-terminal fragment. Upon 
interaction,  the  CLuc  fragment  would  complement 
the missing subdomains in the NLuc fragment [53]. 
Compared  with  the  intact  enzyme,  the  interacted 
fragments  or  restored  protein  showed  significantly 
lower activity [48, 53, 74], indicating a “waste” during 
post-translational activation. Thus, further refinement 
of the activatable reporter genes is still in need to op-
timize the function for in vivo applications. 
Conclusion 
It  is  foreseeable  that  activatable  reporter  gene 
molecular imaging will play very important roles in 
studies  related  to  protein-protein  interactions  and 
various physiological and pathological pathways. The 
visual representation, characterization, quantification, 
and  timing  of  these  biological  processes  in  living 
subjects could create unprecedented opportunities to 
complement available in vitro or cell culture method-
ologies  [82].  Particularly,  imaging  with  activatable 
reporters may provide a robust platform which would 
accelerate  the  development  of  new  drugs  that  pro-
mote or inhibit active protein assembly or target to a 
particular pathway.  
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